Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zeo ScientifiX ( (ZEOX) ) has provided an announcement.
On April 21, 2026, ZEO ScientifiX, Inc., a provider of clinical education in regenerative medicine, announced it had surpassed training 500 clinicians through its one-day Masterclass series on regenerative biologics compliance. Held monthly at Nova Southeastern University’s Center of Innovation and drawing more than 70 attendees per session, the program focuses on Florida’s regulatory requirements, evidence-based science, and operational frameworks for responsibly integrating stem cell and extracellular vesicle therapies into medical practices.
Positioning itself around an “education beats promotion” philosophy amid rising scrutiny of regenerative medicine, ZEO ScientifiX uses a multidisciplinary faculty of healthcare attorneys, researchers, and veteran clinicians to address ethical sourcing, manufacturing quality, risk mitigation, and turnkey practice solutions. Executives framed the milestone as a defining moment that extends standardized protocols and evidence-based frameworks into clinics nationwide, bolstering both the company’s role in shaping compliance standards and the broader push to elevate the standard of care in regenerative biologics and precision longevity medicine.
More about Zeo ScientifiX
ZEO ScientifiX, Inc. is an SEC-reporting, clinical-stage biopharmaceutical company focused on the research, development, and manufacturing of regenerative biologics. Operating out of Nova Southeastern University’s Center of Collaborative Research in Davie, Florida, it provides industry-leading clinical education in regenerative medicine and aims to translate emerging science into scalable clinical solutions for physicians nationwide.
Average Trading Volume: 6,776
Technical Sentiment Signal: Sell
Current Market Cap: $14M
See more insights into ZEOX stock on TipRanks’ Stock Analysis page.